GO
Loading...

It's Time for the Lightning Round!

DTE Energy : "If you're gong to go that route, I'd rather see you do ConEd … I want more growth in that stock." Cramer says DTE is too conservative a stock for a young person to own.

WellPoint : Cramer wishes he bought WellPoint instead of UnitedHealth . He says the company is best of breed. "I would buy, buy, buy, WellPoint."

MedImmune : In another time, Cramer would have called MEDI's management a bunch of idiots, but now that he's a statesman on par with Thomas Jefferson, he'll just say they're misguided. He believes the company should be sold to someone who can do a better job. "MedImmune's not doing as well as it should. I like Celgene , I like Gilead , and I like Genzyme much more."

Eli Lilly : "This is a tough, tough, tough call … the problem with Eli Lilly, and this is the problem I see with much of Big Pharma, it does not have the growth I want." Cramer says he cannot recommend this stock.

Marshall & Ilsley : Cramer likes the company and says it is very forward-thinking. "That's a good stock."

Dendreon : "That is a very speculative stock. It is not for those who want to buy it as a drug company. It is really, really speculative, which is why I have not gone out with it on my show."

Starwood Hotels : "The rumor is that they're going to be for sale. If the stock can go to $90, and if it's for sale, it's just as good as Four Seasons. I want to own Starwood…"

Jim's charitable trust owns UnitedHealth.

Questions? Comments? madmoney@cnbc.com

Symbol
Price
 
Change
%Change
CELG
---
DNDN
---
DTE
---
ED
---
GILD
---
HOT
---
LLY
---
WLP
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.